HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens

BACKGROUND: Accurate evaluation of human epidermal growth factor receptor type-2 (HER2) status based on core needle biopsy (CNB) specimens is mandatory for identification of patients with primary breast cancer who will benefit from primary systemic therapy with trastuzumab. The aim of the present st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuda, Hitoshi, Kurosumi, Masafumi, Umemura, Shinobu, Yamamoto, Sohei, Kobayashi, Takayuki, Osamura, Robert Yoshiyuki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958945/
https://www.ncbi.nlm.nih.gov/pubmed/20925963
http://dx.doi.org/10.1186/1471-2407-10-534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958945/
https://www.ncbi.nlm.nih.gov/pubmed/20925963
http://dx.doi.org/10.1186/1471-2407-10-534

Ejemplares similares